Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mining mountains of data to outsmart diabetes complications

NCT ID NCT07731399

Knowledge-focused Sponsor: Guardian Research Network, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 28, 2026 · Last updated Aug 19, 2026 · Updated 4 times

Summary

This study is collecting blood, stool, genetic information, and health records from 1,200 Medicaid patients in South Carolina — some with type 2 diabetes and some without. Researchers will analyze this data to find patterns that could predict chronic kidney disease, a common complication of diabetes. The goal is to improve early detection and eventually develop better strategies to prevent or reverse diabetes-related health problems.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors predict kidney disease earlier in people with type 2 diabetes and point toward new ways to prevent or treat it.
What could go wrong
This is an observational study, not a treatment trial, so it will not directly test any therapy. The findings may take years to translate into practical changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Oct 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

South Carolina Medicaid-enrolled participants

Ages

40 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

INCLUSION CRITERIA: All Participants: * 40 to 70 years of age (inclusive) at enrollment * Enrolled as Medicaid recipients * Ability to provide informed consent and authorization for release of relevant protected health information or personal data * Ability to provide a blood sample(s) of up to 70 mL and other required biospecimens, including genetic samples. T2D Group: • Current diagnosis of Type 2 diabetes OR a blood level of hemoglobin A1c equal to or greater than 6.5% at any time within the past 12 months Control Group: * Blood level of hemoglobin A1c less than or equal to 5.6% at time of enrollment * No diagnosis of Type 2 diabetes EXCLUSION CRITERIA: * Pregnancy at time of enrollment (by self-report of pregnancy status) * Lack of fluency in spoken and written English * Type 1 diabetes or any other type of diabetes besides Type 2 diabetes * Active cancer diagnosis or cancer that achieved complete remission within three (3) years prior to enrollment, other than non-melanoma skin cancer (e.g. malignant basal cell neoplasm of skin and/or squamous cell carcinoma of skin) * Major Adverse Cardiovascular Events within two (2) years prior to enrollment * Chronic Obstructive Pulmonary Disease * Cognitive impairment or neurodegenerative diseases (e.g., Alzheimer's disease, dementia, multiple sclerosis, Parkinson's disease, etc.) * Pancreatitis or other diseases of the pancreas (besides diabetes) * The participant is, in the opinion of the investigator, unlikely to be able to complete all study requirements

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy controls are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy controls Type 2 diabetes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Clemson Health Clinic at Orangeburg

    RECRUITING

    Orangeburg, South Carolina, 29118, United States

  • Clemson Health Clinic at Walhalla

    RECRUITING

    Walhalla, South Carolina, 29691, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.